BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26377184)

  • 1. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ca/anti-ARHGAP26 antibodies associated with cerebellar atrophy and cognitive decline.
    Doss S; Nümann A; Ziegler A; Siebert E; Borowski K; Stöcker W; Prüss H; Wildemann B; Endres M; Jarius S
    J Neuroimmunol; 2014 Feb; 267(1-2):102-4. PubMed ID: 24439423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
    Jarius S; Martínez-García P; Hernandez AL; Brase JC; Borowski K; Regula JU; Meinck HM; Stöcker W; Wildemann B; Wandinger KP
    J Neuroinflammation; 2013 Jan; 10():7. PubMed ID: 23320754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
    Mitoma H; Honnorat J; Yamaguchi K; Manto M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
    Jarius S; Metz I; König FB; Ruprecht K; Reindl M; Paul F; Brück W; Wildemann B
    Mult Scler; 2016 Oct; 22(12):1541-1549. PubMed ID: 26869529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
    Jarius S; Wandinger KP; Horn S; Heuer H; Wildemann B
    J Neuroinflammation; 2010 Mar; 7():21. PubMed ID: 20226058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
    Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
    J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
    Jarius S; Komorowski L; Regula JU; Haas J; Brakopp S; Wildemann B
    J Neurol; 2022 Oct; 269(10):5420-5430. PubMed ID: 35624318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
    Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L
    J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody.
    Shiihara T; Kato M; Konno A; Takahashi Y; Hayasaka K
    Brain Dev; 2007 May; 29(4):254-6. PubMed ID: 17049194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Vestibulocerebellar Syndromes.
    Narayan RN; McKeon A; Fife TD
    Semin Neurol; 2020 Feb; 40(1):97-115. PubMed ID: 31958862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of acute cerebellar ataxia following infectious mononucleosis accompanied by intrathecal anti-glutamate receptor δ2 antibody].
    Murakami H; Iijima S; Kawamura M; Takahashi Y; Ichikawa H
    Rinsho Shinkeigaku; 2013; 53(7):555-8. PubMed ID: 23892968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
    Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
    Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies.
    Jarius S; Wildemann B; Stöcker W; Moser A; Wandinger KP
    J Neuroimmunol; 2015 Sep; 286():79-82. PubMed ID: 26298328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo.
    Liao YJ; Safa P; Chen YR; Sobel RA; Boyden ES; Tsien RW
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2705-10. PubMed ID: 18272482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.